Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Sandborn

Showing results (151-160 of 186) with videos related to

Pageof 19
Sort By:
Abdominal Imaging|June 14, 2008
CT enterography and fistulizing Crohn's disease: clinical benefit and radiographic findingsFargol Booya, Salma Akram, Joel G Fletcher, et al.
Gut|October 16, 2001
Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazideP W Lowry, C L Franklin, A L Weaver, et al.
Gut|February 15, 2007
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trialW J Sandborn, S B Hanauer, P Rutgeerts, et al.
Annals of Internal Medicine|March 1, 1997
Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trialW J Sandborn, W J Tremaine, K P Offord, et al.
Gut|September 11, 2015
IOIBD technical review on endoscopic indices for Crohn's disease clinical trialsL Vuitton, P Marteau, W J Sandborn, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2015
Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitisP Rutgeerts, B G Feagan, C W Marano, et al.
Alimentary Pharmacology & Therapeutics|January 12, 2017
Review article: dose optimisation of infliximab for acute severe ulcerative colitisP Hindryckx, G Novak, N Vande Casteele, et al.
Gut|February 10, 2009
Adalimumab for the treatment of fistulas in patients with Crohn's diseaseJ-F Colombel, D A Schwartz, W J Sandborn, et al.
Alimentary Pharmacology & Therapeutics|April 27, 2018
Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitisC Ma, L Guizzetti, R Panaccione, et al.
Journal of Clinical Pharmacology|May 1, 1997
Pharmacokinetics of nicotine tartrate after single-dose liquid enema, oral, and intravenous administrationB J Zins, W J Sandborn, D C Mays, et al.
Pageof 19

Showing results (151-160 of 186) with videos related to

Sort By:
Pageof 19
Abdominal Imaging|June 14, 2008
CT enterography and fistulizing Crohn's disease: clinical benefit and radiographic findingsFargol Booya, Salma Akram, Joel G Fletcher, et al.
Gut|October 16, 2001
Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazideP W Lowry, C L Franklin, A L Weaver, et al.
Gut|February 15, 2007
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trialW J Sandborn, S B Hanauer, P Rutgeerts, et al.
Annals of Internal Medicine|March 1, 1997
Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trialW J Sandborn, W J Tremaine, K P Offord, et al.
Gut|September 11, 2015
IOIBD technical review on endoscopic indices for Crohn's disease clinical trialsL Vuitton, P Marteau, W J Sandborn, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2015
Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitisP Rutgeerts, B G Feagan, C W Marano, et al.
Alimentary Pharmacology & Therapeutics|January 12, 2017
Review article: dose optimisation of infliximab for acute severe ulcerative colitisP Hindryckx, G Novak, N Vande Casteele, et al.
Gut|February 10, 2009
Adalimumab for the treatment of fistulas in patients with Crohn's diseaseJ-F Colombel, D A Schwartz, W J Sandborn, et al.
Alimentary Pharmacology & Therapeutics|April 27, 2018
Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitisC Ma, L Guizzetti, R Panaccione, et al.
Journal of Clinical Pharmacology|May 1, 1997
Pharmacokinetics of nicotine tartrate after single-dose liquid enema, oral, and intravenous administrationB J Zins, W J Sandborn, D C Mays, et al.
Pageof 19